Sensei Biotherapeutics: Cash, Cash Equivalents and Marketable Securities Were $58.1 M as of March 31 >SNSE
Sensei Biotherapeutics: Cash, Cash Equivalents and Marketable Securities Were $58.1 M as of March 31 >SNSE
Sensei Biotherapeutics:截至3月31日,现金、现金等价物和有价证券为5,810万美元 >SNSE
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册